KAIST

Hyung Kyu Lim, a former President of the KAIST Alumni Association, has donated 100 million won as the prize money for the School Song and National Anthem Challenge. This donation will be used as prize money starting from the 2026 competition and is expected to play a significant role in spreading KAIST's educational culture and fostering a sense of community. < Photo 1. KAIST President Kwang-Hyung Lee (left) and the former Alumni Association President Hyung Kyu Lim at the ceremony for th

< Professor Se Kwon Kim of the Department of Physics (left), Dr. Zarzuela of the University of Mainz, Germany (right) > What if the magnon Hall effect, which processes information using magnons (spin waves) capable of current-free information transfer with magnets, could overcome its current limitation of being possible only on a 2D plane? If magnons could be utilized in 3D space, they would enable flexible design, including 3D circuits, and be applicable in various fields such as nex

A Gift of Life on Teachers' Day: Baby Geese Born at KAIST Pond On Teachers' Day, a meaningful miracle of life arrived at the KAIST campus. A pair of geese gave birth to two goslings by the duck pond. < On Teachers' Day, a pair of geese and their goslings leisurely swim in the pond. > The baby goslings, covered in yellow down, began exploring the pond's edge, scurrying about, while their aunt geese steadfastly stood by. Their curious glances, watchful gazes, playful hops on water

< Professor Minee Choi of the Department of Brain and Cognitive Sciences (top left). Professor Sonia Gandhi (top right) and Professor Klenerman of the University College London (bottom right) > Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroi

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting the urgent need for new strategies tailored to both responders and non-responders. KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy—opening